Patents by Inventor Michael Karbiener

Michael Karbiener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS
    Publication number: 20160298115
    Abstract: The present invention relates to compositions comprising an agent, like a polynucleotide, which induces or upregulates expression of UCP1 for use in treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject. The present invention also relates to a method of treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject comprising administrating a composition comprising a polynucleotide which induces or upregulates expression of UCP1.
    Type: Application
    Filed: March 22, 2016
    Publication date: October 13, 2016
    Applicants: Centre National de la Recherche Scientifique, l'Université Nice Sophia Antipolis
    Inventors: Marcel SCHEIDELER, Michael KARBIENER, Ez-Zoubir AMRI, Gérard AILHAUD, Christian DANI
  • UCP1 (thermogenin)—inducing agents for use in the treatment of a disorder of the energy homeostasis
    Patent number: 9320756
    Abstract: The present invention relates to compositions comprising an agent, like a polynucleotide, which induces or upregulates expression of UCP1 for use in treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject. The present invention also relates to a method of treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject comprising administrating a composition comprising a polynucleotide which induces or upregulates expression of UCP1.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: April 26, 2016
    Assignees: Centre National de la Recherche Scientifique, l'Université Nice Sophia Antipolis
    Inventors: Marcel Scheideler, Michael Karbiener, Ez-Zoubir Amri, Gérard Ailhaud, Christian Dani
  • UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS
    Publication number: 20130331440
    Abstract: The present invention relates to compositions comprising an agent, like a polynucleotide, which induces or upregulates expression of UCP1 for use in treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject. The present invention also relates to a method of treating or preventing a disorder of the energy homeostasis, overweight, adiposity, obesity, metabolic syndrome or related diseases or disorders in a subject comprising administrating a composition comprising a polynucleotide which induces or upregulates expression of UCP1.
    Type: Application
    Filed: May 6, 2011
    Publication date: December 12, 2013
    Applicant: TECHNISCHE UNIVERSITAT GRAZ
    Inventors: Marcel Scheideler, Michael Karbiener, Ez-Zoubir Amri, Gérard Ailhaud, Christian Dani